High-resolution dose-response screening using droplet-based microfluidics

A critical early step in drug discovery is the screening of a chemical library. Typically, promising compounds are identified in a primary screen and then more fully characterized in a dose-response analysis with 7-10 data points per compound. Here, we describe a robust microfluidic approach that in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Proceedings of the National Academy of Sciences - PNAS 2012-01, Vol.109
Hauptverfasser: Miller, Oliver, Harrak, Abdeslam El, Mangeat, Thomas, Baret, Jean-Christophe, Frenz, Lucas, Debs, Bachir El, Mayot, Estelle, Samuels, Michael L, Rooney, Eamonn K, Dieu, Pierre, Galvan, Martin, Link, Darren R, Griffiths, Andrew D
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A critical early step in drug discovery is the screening of a chemical library. Typically, promising compounds are identified in a primary screen and then more fully characterized in a dose-response analysis with 7-10 data points per compound. Here, we describe a robust microfluidic approach that increases the number of data points to approximately 10,000 per compound. The system exploits Taylor-Aris dispersion to create concentration gradients, which are then segmented into picoliter microreactors by droplet-based mi-crofluidics. The large number of data points results in IC 50 values that are highly precise (2.40% at 95% confidence) and highly reproducible (CV 2.45%, n 16). In addition, the high resolution of the data reveals complex dose-response relationships unam-biguously. We used this system to screen a chemical library of 704 compounds against protein tyrosine phosphatase 1B, a diabetes, obesity, and cancer target. We identified a number of novel inhi-bitors, the most potent being sodium cefsulodine, which has an IC 50 of 27 0.83 µM.
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas